Central sleep apnea and chronic heart failure

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Central sleep apnea with Cheyne-Stokes respiration (CSR) affects 40% of chronic heart failure (CHF) patients.
• CSR involves periodic fluctuations in breathing, wakefulness, blood pressure, and heart rate.
• Mechanisms include reduced oxygen/carbon dioxide stores, hypocapnia, prolonged circulation, and high hypercapnic ventilatory response.

Purpose of the Study:

• To investigate the influence of CSR on the course of CHF.
• To determine if CSR treatment impacts CHF mortality.

Main Methods:

• Observational analysis of patients with CHF and CSR.
• Review of mechanisms contributing to CSR oscillations.
• Assessment of CSR's impact on sympathetic activity and CHF prognosis.

Main Results:

• CSR leads to repetitive desaturations and arousals.
• Increased sympathetic activity due to CSR negatively affects left ventricular function.
• CSR is associated with reduced exercise tolerance and poor prognosis in CHF.

Conclusions:

• CSR is expected to unfavorably influence the course of CHF.
• Controlled studies with adequate sample size are needed to ascertain if CSR treatment affects CHF mortality.